title: The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!
abstract: Kinetoplastids are unicellular, eukaryotic, flagellated protozoans containing the eponymous kinetoplast. Within this order, the family of trypanosomatids are responsible for some of the most serious human diseases, including Chagas disease (Trypanosoma cruzi), sleeping sickness (Trypanosoma brucei spp.), and leishmaniasis (Leishmania spp). Although cAMP is produced during the life cycle stages of these parasites, its signaling pathways are very different from those of mammals. The absence of G-protein-coupled receptors, the presence of structurally different adenylyl cyclases, the paucity of known cAMP effector proteins and the stringent need for regulation of cAMP in the small kinetoplastid cells all suggest a significantly different biochemical pathway and likely cell biology. However, each of the main kinetoplastid parasites express four class 1-type cyclic nucleotide-specific phosphodiesterases (PDEA-D), which have highly similar catalytic domains to that of human PDEs. To date, only TbrPDEB, expressed as two slightly different isoforms TbrPDEB1 and B2, has been found to be essential when ablated. Although the genomes contain reasonably well conserved genes for catalytic and regulatory domains of protein kinase A, these have been shown to have varied structural and functional roles in the different species. Recent discovery of a role of cAMP/AMP metabolism in a quorum-sensing signaling pathway in T. brucei, and the identification of downstream cAMP Response Proteins (CARPs) whose expression levels correlate with sensitivity to PDE inhibitors, suggests a complex signaling cascade. The interplay between the roles of these novel CARPs and the quorum-sensing signaling pathway on cell division and differentiation makes for intriguing cell biology and a new paradigm in cAMP signal transduction, as well as potential targets for trypanosomatid-specific cAMP pathway-based therapeutics.
authors.affiliation: Wellcome Trust Centre for Molecular Parasitology, University of Glasgow , Glasgow, UK ; Institute of Infection, Inflammation and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow, UK ; Department of Laboratory Technology, Division of Medical Laboratory Technology, University of Cape Coast , Cape Coast, Ghana.
authors.forename: Daniel N A
authors.initials: DN
authors.lastname: Tagoe
authors.affiliation: Institute of Infection, Inflammation and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow, UK.
authors.forename: Titilola D
authors.initials: TD
authors.lastname: Kalejaiye
authors.affiliation: Institute of Infection, Inflammation and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow , Glasgow, UK.
authors.forename: Harry P
authors.initials: HP
authors.lastname: de Koning
keywords: Leishmania; PKA; Trypanosoma brucei; Trypanosoma cruzi; adenylyl cyclase; cAMP; kinase; phosphodiesterase